The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
4-Chlorodehydromethyltestosterone, also known as Oral Turinabol or simply Turinabol, is a synthetic anabolic androgenic steroid (AAS). It was developed in the 1960s by East German scientists as a performance-enhancing drug for their athletes.
Turinabol is derived from testosterone and has an added chloro group at the 4th carbon position, which enhances its anabolic properties while reducing its androgenic effects. This modification makes it less likely to cause side effects such as hair loss, acne, and prostate enlargement compared to other steroids.
The mechanism of action of Turinabol is similar to other AAS. It binds to androgen receptors in various tissues, including muscle cells, promoting protein synthesis and increasing nitrogen retention. This leads to an increase in muscle mass, strength, and endurance.
Turinabol also has a low affinity for aromatase, an enzyme responsible for converting testosterone into estrogen. As a result, it has a minimal risk of estrogen-related side effects like water retention and gynecomastia.
Overall, Turinabol is known for providing moderate gains in muscle mass and strength without excessive water retention or significant androgenic side effects. It is often used by athletes and bodybuilders during cutting or lean bulking cycles to enhance performance and achieve a more defined physique.